These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7666572)

  • 1. Effects of aprindine on electrophysiological properties of the atrial muscle in man.
    Hano O; Konoe A; Hirata T; Kaibara M; Isomoto S; Shimizu A; Centurion O; Hayano M; Yano K
    Jpn Circ J; 1995 Jun; 59(6):337-46. PubMed ID: 7666572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo.
    Esato M; Shimizu A; Chun YH; Tatsuno H; Yamagata T; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):321-7. PubMed ID: 8856490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flecainide on the electrophysiological properties of atrial vulnerability in humans.
    Yoshiga Y; Shimizu A; Yamagata T; Esato M; Ueyama T; Ohmura M; Itagaki K; Kimura M; Kakugawa H; Doi M; Matsuzaki M
    Circ J; 2003 May; 67(5):437-42. PubMed ID: 12736484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.
    Zipes DP; Gaum WE; Foster PR; Rosen KM; Wu D; Amat-Y-Leon F; Noble RJ
    Am J Cardiol; 1977 Oct; 40(4):586-96. PubMed ID: 910722
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
    Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
    Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
    Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological properties of the left atrium evaluated by coronary sinus pacing in patients with atrial fibrillation.
    Ishimatsu T; Hayano M; Hirata T; Iliev II; Komiya N; Nakao K; Iwamoto K; Tsukahara K; Sakamoto R; Ueyama C; Yano K
    Pacing Clin Electrophysiol; 1999 Dec; 22(12):1739-46. PubMed ID: 10642126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependency on atrial electrophysiological properties of appearance of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome: evidence from atrial vulnerability before and after radiofrequency catheter ablation and surgical cryoablation.
    Muraoka Y; Karakawa S; Yamagata T; Matsuura H; Kajiyama G
    Pacing Clin Electrophysiol; 1998 Feb; 21(2):438-46. PubMed ID: 9507546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation.
    Konoe A; Fukatani M; Tanigawa M; Isomoto S; Kadena M; Sakamoto T; Mori M; Shimizu A; Hashiba K
    Pacing Clin Electrophysiol; 1992 Jul; 15(7):1040-52. PubMed ID: 1378596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone.
    Gondo N; Kumagai K; Matsuo K; Annoura M; Moroe K; Arakawa K
    Cardiology; 1994; 84(4-5):292-7. PubMed ID: 8187115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal-averaged P wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.
    Maia IG; Cruz Filho FE; Fagundes ML; Boghossian SH; Vanheusden L; Sa RM; Alves PA
    J Am Coll Cardiol; 1995 Nov; 26(5):1310-4. PubMed ID: 7594048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
    Centurión OA; Shimizu A; Isomoto S; Konoe A
    Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial electrophysiological features in patients with Wolff-Parkinson-White and atrial fibrillation: absence of rate adaptation of intraatrial conduction time parameters.
    Riccardi R; Gaita F; Giustetto C; Gardiol S
    Pacing Clin Electrophysiol; 1997 May; 20(5 Pt 1):1318-27. PubMed ID: 9170133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic properties of atrial muscle in paroxysmal atrial fibrillation.
    Hashiba K; Tanigawa M; Fukatani M; Shimizu A; Konoe A; Kadena M; Mori M
    Am J Cardiol; 1989 Dec; 64(20):20J-23J. PubMed ID: 2480704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
    Inoue H; Zipes DP
    Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing.
    Hirao K; Okishige K; Suzuki F; Hiejima K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():819-25. PubMed ID: 1931758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of verapamil on electrophysiological properties in paroxysmal atrial fibrillation.
    Kumagai K; Matsuo K; Ono M; Yamanouchi Y; Moroe K; Hamasaki N; Arakawa K
    Pacing Clin Electrophysiol; 1993 Feb; 16(2):309-16. PubMed ID: 7680460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the electrophysiological effects of aprindine in man, with particular regard to the ventricular preexcitation syndrome (author's transl)].
    Vergara G; Disertori M; Molinis G; Inama G; Antonini L; Del Favero A; Stefenelli C; Furlanello F
    G Ital Cardiol; 1979; 9(6):597-606. PubMed ID: 488596
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.
    Reid PR; Greene HL; Varghese PJ
    Br Heart J; 1977 Dec; 39(12):1353-60. PubMed ID: 603737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and atrial vulnerability in the Wolff-Parkinson-White syndrome.
    Asano Y; Kaneko K; Matsumoto K; Saito J; Yamamoto T; Dohi Y
    Jpn Circ J; 1991 Mar; 55(3):287-96. PubMed ID: 2030555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.